Dr. Lindeman has over 15 years of experience in successfully working with clients to develop, commercialize and defend their patent portfolios. His practice includes preparing and prosecuting patent applications in the US and internationally; rendering opinions on validity and infringement; conducting IP due diligence; assessing freedom to operate; and counseling in litigation. Dr. Lindeman practice focuses on the chemical and pharmaceutical industries, with a particular area of expertise in patenting crystalline forms of pharmaceuticals, e.g. polymorph and co-crystal patents.
An adjunct professor at American University’s Washington College of Law, Dr. Lindeman teaches courses on patent prosecution and international patent law. He is currently the chair of the Chemical Practice Committee for the American Intellectual Property Law Association. Prior to joining O’Brien Jones, Dr. Lindeman was a partner and the Patents Practice Group Leader at Nixon Peabody, LLP.
Dr. Lindeman is a frequent lecturer on patent topics. He has spoken in the US and abroad on topics such as patenting crystalline forms, inequitable conduct and patent reform. Dr. Lindeman has also authored articles in both legal and scientific journals.
Degrees & Universities
- J.D., Georgetown University Law Center (cum laude)
- Ph.D., University of South Carolina
- B.A., West Virginia University